Prof. Sylvain Lehmann was trained as an M.D. (1991, Strasbourg University, School of Medicine, Fr) and a Ph.D. (1992: Cellular and Molecular Biology). He was the recipient of a Howard Hughes fellowship for physician and spent four years in Washington University, MO USA as a postdoctoral fellow and a research assistant professor (1993-1996). There he started working on Prion and Alzheimer Disease using cell culture and cell biological tools. From 1997-2002 he was INSERM Senior Researcher and in 2003 obtained a position of professor of Biochemistry at the Medical School of Montpellier. As head of a Research Group at the Institute of Human Genetics, his work is focusing on cell biology of neurodegenerative disorders. His clinical unit at the University Hospital of Montpellier is in charge of the biological diagnosis of neurodegenerative disorders and he recently set up a reference Neurological biobank. He is responsible of the “Clinical Proteomics Platform” of the hospital. His laboratory is involved in innovative program on biomarker discovery and detection using mass spectrometry and biochips. He is a vice-president of the “Société Française de Biologie Clinique” (SFBC) in charge of its Scientific Committee. He is a member of the “Biospecimen Science” working group of the International Society for Biological and Environmental Repositories (ISBER) and he chairs the Working Group “Clinical Quantitative Mass Spectrometry Proteomics” of the International Federation of Clinical Chemistry and laboratory medicine (IFCC).
Biography Updated on 18 October 2011